SELINEXOR | N212306 | KARYOPHARM THERAPEUTICS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8999996 | Jul 3, 2033 | — | Yes | Yes | — | — |
| 9079865 | Jul 26, 2032 | — | — | — | — | |
| 9714226 | Jul 26, 2032 | — | Yes | Yes | — | — |
| 10519139 | Aug 14, 2035 | — | Yes | Yes | — | |
| 10544108 | Jul 26, 2032 | — | — | — | — | |
| 11034660 | Jul 26, 2032 | — | — | — | — | |
| 11746102 | Aug 14, 2035 | — | — | — | — | |
| 11753401 | Aug 14, 2035 | — | — | Yes | — | |
| 11787771 | Jul 26, 2032 | — | — | — | — | |
| 11807629 | Aug 14, 2035 | — | Yes | Yes | — | — |
| 12291508 | Jul 26, 2032 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| ODE-257 | Jul 3, 2026 | Expired |
| ODE-310 | Jun 22, 2027 | < 1 year |
| ODE-346 | Dec 18, 2027 | Active |
Karyopharm Therapeutics modified the patent use code for selinexor (XPOVIO, NDA 212306) from U-2855 to U-2584, indicating a change in which listed patent protections are associated with the drug product.
Old: U-2855
New: U-2584
Karyopharm Therapeutics modified the patent use code for a listed patent covering XPOVIO (selinexor) in NDA 212306, changing from U-2855 to U-3018, indicating a different method-of-use or indication covered by patent 9,079,865.
Old: U-2855
New: U-3018
Karyopharm updated the patent use code for selinexor (XPOVIO) from U-2855 to U-3018, reflecting a revised indication mapping for U.S. Patent 11,787,771 listed in the Orange Book.
Old: U-2855
New: U-3018
XPOVIO (selinexor) patent use code changed from U-2855 to U-3018 in the Orange Book listing for NDA 212306.
Old: U-2855
New: U-3018
Karyopharm Therapeutics modified the patent use code for selinexor (XPOVIO, NDA 212306) from U-2855 to U-3018, indicating a change in the labeled indication covered by U.S. Patent 10,519,139.
Old: U-2855
New: U-3018
Karyopharm Therapeutics modified the patent use code for selinexor (XPOVIO, NDA 212306) from U-2855 to U-2584 in the Orange Book patent listing.
Old: U-2855
New: U-2584
Karyopharm Therapeutics updated the patent use code for a listed patent covering XPOVIO (selinexor) from U-2855 to U-3018 in the Orange Book.
Old: U-2855
New: U-3018